117 related articles for article (PubMed ID: 15567486)
1. Immunohistochemical study of hnRNP B1 in the postmortem temporal cortices of patients with Alzheimer's disease.
Ishikawa M; Mizukami K; Iwakiri M; Kamma H; Ikonomovic MD; Dekosky ST; Asada T
Neurosci Res; 2004 Dec; 50(4):481-4. PubMed ID: 15567486
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of the hnRNP A2 and B1 in the hippocampal formations of brains with Alzheimer's disease.
Mizukami K; Ishikawa M; Iwakiri M; Ikonomovic MD; Dekosky ST; Kamma H; Asada T
Neurosci Lett; 2005 Sep; 386(2):111-5. PubMed ID: 15993539
[TBL] [Abstract][Full Text] [Related]
3. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology.
Schönheit B; Zarski R; Ohm TG
Neurobiol Aging; 2004 Jul; 25(6):697-711. PubMed ID: 15165691
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.
Hof PR; Cox K; Morrison JH
J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598
[TBL] [Abstract][Full Text] [Related]
5. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evidence for macroautophagy in neurones and endothelial cells in Alzheimer's disease.
Ma JF; Huang Y; Chen SD; Halliday G
Neuropathol Appl Neurobiol; 2010 Jun; 36(4):312-9. PubMed ID: 20102518
[TBL] [Abstract][Full Text] [Related]
7. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
[TBL] [Abstract][Full Text] [Related]
9. CCR1 is an early and specific marker of Alzheimer's disease.
Halks-Miller M; Schroeder ML; Haroutunian V; Moenning U; Rossi M; Achim C; Purohit D; Mahmoudi M; Horuk R
Ann Neurol; 2003 Nov; 54(5):638-46. PubMed ID: 14595653
[TBL] [Abstract][Full Text] [Related]
10. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease.
Hatanpää K; Brady DR; Stoll J; Rapoport SI; Chandrasekaran K
Ann Neurol; 1996 Sep; 40(3):411-20. PubMed ID: 8797530
[TBL] [Abstract][Full Text] [Related]
11. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y
Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433
[TBL] [Abstract][Full Text] [Related]
12. Thiazin red as a neuropathological tool for the rapid diagnosis of Alzheimer's disease in tissue imprints.
Luna-Muñoz J; Peralta-Ramirez J; Chávez-Macías L; Harrington CR; Wischik CM; Mena R
Acta Neuropathol; 2008 Nov; 116(5):507-15. PubMed ID: 18810470
[TBL] [Abstract][Full Text] [Related]
13. High-throughput quantification of Alzheimer's disease pathological markers in the post-mortem human brain.
Byrne UT; Ross JM; Faull RL; Dragunow M
J Neurosci Methods; 2009 Jan; 176(2):298-309. PubMed ID: 18835409
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic cytochrome c immunolabelling in dystrophic neurites in Alzheimer's disease.
Woodhouse A; Vickers JC; Dickson TC
Acta Neuropathol; 2006 Oct; 112(4):429-37. PubMed ID: 16855832
[TBL] [Abstract][Full Text] [Related]
15. [Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].
Leel-Ossy L; Kindler M; Szucs I; Schwarcz T
Ideggyogy Sz; 2006 May; 59(5-6):164-77. PubMed ID: 16786711
[TBL] [Abstract][Full Text] [Related]
16. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
Williams S; Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825
[TBL] [Abstract][Full Text] [Related]
17. Calbindin D-28k immunoreactivity in the temporal neocortex in patients with Alzheimer's disease.
Ferrer I; Tuñon T; Soriano E; del Rio A; Iraizoz I; Fonseca M; Guionnet N
Clin Neuropathol; 1993; 12(1):53-8. PubMed ID: 8440080
[TBL] [Abstract][Full Text] [Related]
18. Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease.
Thangavel R; Sahu SK; Van Hoesen GW; Zaheer A
Neuroscience; 2009 May; 160(2):427-33. PubMed ID: 19250962
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactivity patterns in neurofibrillary tangles of the inferior temporal cortex in Alzheimer disease.
Duong T; Gallagher KA
Mol Chem Neuropathol; 1994 Jun; 22(2):105-22. PubMed ID: 7916770
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes.
MacDonald AB
Med Hypotheses; 2007; 68(4):822-5. PubMed ID: 17055667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
